John Burns
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
John T.
Burns is currently Chief Financial Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. since 2023.
Formerly, Mr. Burns was Manager-Securities & Exchange Reporting at Pixelworks, Inc. and Chief Accounting Officer at Galena Biopharma, Inc. in 2016.
Education includes undergraduate and graduate degrees from Tulane University (Louisiana).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2026 | 132.373 ( 0,07 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director Financiero/CFO | 30/12/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Pixelworks, Inc.
Pixelworks, Inc. SemiconductorsElectronic Technology Designs, develops and markets visual display processing semiconductors | Electronic Technology |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Health Technology |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.